Back
SPDR® S&P Pharmaceuticals ETF 10K Form
Buy
59
XPH
SPDR® S&P Pharmaceuticals ETF
Last Price:
40.71
Seasonality Move:
4.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive XPH News And Ratings
See the #1 stock for the next 7 days that we like better than XPH
XPH Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.00 |
| Price / Book: | 0 |
Profitability
| Net Income (TTM): | $0 |
|---|---|
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
SPDR® S&P Pharmaceuticals ETF Earnings Forecast
Key SPDR® S&P Pharmaceuticals ETF Financial Ratios
SPDR® S&P Pharmaceuticals ETF Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSEARCA |
|---|---|
| Current Symbol: | XPH |
| CUSIP: | 78464A |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
XPH Technical Analysis vs Fundamental Analysis
Buy
59
SPDR® S&P Pharmaceuticals ETF (XPH)
is a Buy
Is SPDR® S&P Pharmaceuticals ETF a Buy or a Sell?
-
SPDR® S&P Pharmaceuticals ETF stock is rated a Buy
The current SPDR® S&P Pharmaceuticals ETF [XPH] share price is $40.79. The Score for XPH is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.